ATE228132T1 - Trifluoromethylpyrroloindolcarbonsäure und dessen esterderivat sowie ein verfahren zu seiner herstellung - Google Patents

Trifluoromethylpyrroloindolcarbonsäure und dessen esterderivat sowie ein verfahren zu seiner herstellung

Info

Publication number
ATE228132T1
ATE228132T1 AT94908108T AT94908108T ATE228132T1 AT E228132 T1 ATE228132 T1 AT E228132T1 AT 94908108 T AT94908108 T AT 94908108T AT 94908108 T AT94908108 T AT 94908108T AT E228132 T1 ATE228132 T1 AT E228132T1
Authority
AT
Austria
Prior art keywords
trifluoromethylpyrroloindole
production
carboxylic acid
ester derivative
arylsulfonyloxy
Prior art date
Application number
AT94908108T
Other languages
English (en)
Inventor
Shiro Terashima
Yasumichi Fukuda
Yasuo Oomori
Original Assignee
Kyorin Seiyaku Kk
Sagami Chem Res
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kyorin Seiyaku Kk, Sagami Chem Res filed Critical Kyorin Seiyaku Kk
Application granted granted Critical
Publication of ATE228132T1 publication Critical patent/ATE228132T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/10Spiro-condensed systems
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Indole Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Laminated Bodies (AREA)
AT94908108T 1992-08-21 1993-08-19 Trifluoromethylpyrroloindolcarbonsäure und dessen esterderivat sowie ein verfahren zu seiner herstellung ATE228132T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP22286292 1992-08-21
JP20425593A JP3514490B2 (ja) 1992-08-21 1993-08-18 トリフルオロメチルピロロインドールカルボン酸エステル誘導体及びその製造方法
PCT/JP1993/001159 WO1994004535A1 (fr) 1992-08-21 1993-08-19 Derive d'ester carboxylique de trifluoromethylpyrroloindole et procede pour sa fabrication

Publications (1)

Publication Number Publication Date
ATE228132T1 true ATE228132T1 (de) 2002-12-15

Family

ID=26514369

Family Applications (1)

Application Number Title Priority Date Filing Date
AT94908108T ATE228132T1 (de) 1992-08-21 1993-08-19 Trifluoromethylpyrroloindolcarbonsäure und dessen esterderivat sowie ein verfahren zu seiner herstellung

Country Status (13)

Country Link
US (1) US5629430A (de)
EP (1) EP0656360B1 (de)
JP (1) JP3514490B2 (de)
KR (2) KR100312444B1 (de)
AT (1) ATE228132T1 (de)
CA (1) CA2142869C (de)
DE (1) DE69332504T2 (de)
DK (1) DK0656360T3 (de)
ES (1) ES2188608T3 (de)
HU (1) HU221041B1 (de)
PT (1) PT656360E (de)
TW (1) TW394774B (de)
WO (1) WO1994004535A1 (de)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100395083B1 (ko) * 1994-11-29 2004-02-05 자이단호오징 사가미 츄오 카가쿠겡큐쇼 아크릴아미드유도체및그제조방법
AU3463197A (en) * 1996-07-23 1998-02-10 Kyowa Hakko Kogyo Co. Ltd. Dc-89 derivatives
WO1998032757A1 (en) * 1997-01-24 1998-07-30 Kyorin Pharmaceutical Co., Ltd. Pyrroloindole derivatives and intermediates in producing the same
NZ504884A (en) * 1997-12-08 2002-10-25 Scripps Research Inst Synthesis of the dihydroindole C-ring of CC-1065/duocarmycin analogs and certain intermediates
US7129261B2 (en) 2001-05-31 2006-10-31 Medarex, Inc. Cytotoxic agents
JP2006505571A (ja) * 2002-10-15 2006-02-16 リゲル ファーマシューテイカルズ、インコーポレイテッド 置換されたインドール及びhcv阻害剤としてのその使用
GB0403038D0 (en) 2004-02-11 2004-03-17 Novartis Ag Organic compounds
WO2005112919A2 (en) * 2004-05-19 2005-12-01 Medarex, Inc. Self-immolative linkers and drug conjugates
RU2402548C2 (ru) * 2004-05-19 2010-10-27 Медарекс, Инк. Химические линкеры и их конъюгаты
US7781478B2 (en) 2004-07-14 2010-08-24 Ptc Therapeutics, Inc. Methods for treating hepatitis C
WO2006089230A2 (en) * 2005-02-18 2006-08-24 Medarex, Inc. Human monoclonal antibodies to prostate specific membrane antigen (psma)
US7714016B2 (en) * 2005-04-08 2010-05-11 Medarex, Inc. Cytotoxic compounds and conjugates with cleavable substrates
EP1940470B1 (de) * 2005-09-26 2013-04-17 Medarex, Inc. Antikörper-Arzneimittel-Konjugate und deren Anwendung
EA015324B1 (ru) 2005-10-26 2011-06-30 Медарекс, Инк. Способы и соединения для получения аналогов сс-1065
CA2627190A1 (en) 2005-11-10 2007-05-24 Medarex, Inc. Duocarmycin derivatives as novel cytotoxic compounds and conjugates
TWI412367B (zh) 2006-12-28 2013-10-21 Medarex Llc 化學鏈接劑與可裂解基質以及其之綴合物
CA2678514A1 (en) 2007-02-21 2008-08-28 Medarex, Inc. Chemical linkers with single amino acids and conjugates thereof
US9901567B2 (en) 2007-08-01 2018-02-27 Syntarga B.V. Substituted CC-1065 analogs and their conjugates
EP2219619B1 (de) * 2007-11-20 2020-07-15 Lankenau Institute for Medical Research Disulfid-chemotherapeutika und anwendungsverfahren dafür
CA2742568C (en) 2008-11-03 2017-09-26 Syntarga B.V. Novel cc-1065 analogs and their conjugates
US8697391B2 (en) 2009-05-15 2014-04-15 Lankenau Institute For Medical Research Method of determining cell number or viability using hydroxyethyldisulfide
EP3108886B1 (de) 2010-04-21 2020-06-17 Syntarga B.V. Konjugate von cc-1065 analogen und bifunktionelle linker
CA2891280C (en) 2012-11-24 2018-03-20 Hangzhou Dac Biotech Co., Ltd. Hydrophilic linkers and their uses for conjugation of drugs to cell binding molecules
RU2686085C2 (ru) 2014-01-10 2019-04-24 Синтон Байофармасьютикалс Б. В. Конъюгаты антитело-лекарственное средство (adc) с дуокармицином, применяемые для лечения рака эндометрия
TR201810856T4 (tr) 2014-01-10 2018-08-27 Synthon Biopharmaceuticals Bv CYS'le bağlı antikor-ilaç konjugatlarını saflaştırmak için usul.
JP6342517B2 (ja) 2014-01-10 2018-06-13 シントン・バイオファーマシューティカルズ・ビー.ブイ.Synthon Biopharmaceuticals B.V. 改善されたインビボ抗腫瘍活性を示すデュオカルマイシンadc
CN106414465B (zh) 2014-02-28 2021-11-16 杭州多禧生物科技有限公司 带电荷链接体及其在共轭反应上的应用
NZ739830A (en) 2015-07-12 2021-12-24 Hangzhou Dac Biotech Co Ltd Bridge linkers for conjugation of cell-binding molecules
US9839687B2 (en) 2015-07-15 2017-12-12 Suzhou M-Conj Biotech Co., Ltd. Acetylenedicarboxyl linkers and their uses in specific conjugation of a cell-binding molecule
CN116143678A (zh) 2016-11-14 2023-05-23 杭州多禧生物科技有限公司 偶联连接体,含有此连接体的细胞结合分子-药物偶联物及其制备和应用
MX2023002947A (es) * 2020-09-11 2023-06-06 Univ California Composiciones y métodos para el tratamiento de distrofias musculares.
CN112724068A (zh) * 2020-12-30 2021-04-30 蔡桂坡 具有hdac抑制活性的吲哚类衍生物的合成方法及肿瘤应用
WO2022078524A2 (en) 2021-11-03 2022-04-21 Hangzhou Dac Biotech Co., Ltd. Specific conjugation of an antibody

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4978757A (en) * 1984-02-21 1990-12-18 The Upjohn Company 1,2,8,8a-tetrahydrocyclopropa (C) pyrrolo [3,2-e)]-indol-4(5H)-ones and related compounds
JP2598116B2 (ja) * 1988-12-28 1997-04-09 協和醗酵工業株式会社 新規物質dc113
JP2510335B2 (ja) * 1989-07-03 1996-06-26 協和醗酵工業株式会社 Dc―88a誘導体
JP3037965B2 (ja) * 1990-06-20 2000-05-08 財団法人相模中央化学研究所 2―アルコキシカルボニル―2―メチル―1―オキソ―1,2,3,6,7,8―ヘキサヒドロ―ベンゾ〔1,2―b;4,3―b´〕ジピロール誘導体
JPH0499774A (ja) * 1990-08-14 1992-03-31 Sagami Chem Res Center 2―エピデュオカルマイシンaおよびその製造中間体

Also Published As

Publication number Publication date
JPH06116269A (ja) 1994-04-26
DE69332504T2 (de) 2003-10-02
AU4761893A (en) 1994-03-15
CA2142869C (en) 2002-01-01
WO1994004535A1 (fr) 1994-03-03
EP0656360A1 (de) 1995-06-07
HU9500494D0 (en) 1995-04-28
TW394774B (en) 2000-06-21
KR100312445B1 (ko) 2001-11-09
AU689443B2 (en) 1998-04-02
US5629430A (en) 1997-05-13
CA2142869A1 (en) 1994-03-03
HUT71493A (en) 1995-11-28
PT656360E (pt) 2003-02-28
DE69332504D1 (de) 2003-01-02
EP0656360B1 (de) 2002-11-20
HU221041B1 (hu) 2002-07-29
EP0656360A4 (de) 1995-08-30
JP3514490B2 (ja) 2004-03-31
KR100312444B1 (ko) 2002-02-28
DK0656360T3 (da) 2003-03-17
ES2188608T3 (es) 2003-07-01

Similar Documents

Publication Publication Date Title
ATE228132T1 (de) Trifluoromethylpyrroloindolcarbonsäure und dessen esterderivat sowie ein verfahren zu seiner herstellung
DE69533277D1 (de) Dc-89 derivat
ATE229527T1 (de) Pyrazolopyridylpyrazinon-derivate und ein verfahren zu ihrer herstellung
ATE165601T1 (de) Benzopyran-verbindungen, verfahren zu ihrer herstellung und ihre verwendung als zellenschutzmittel
NO913087L (no) Ny tricyklisk forbindelse eller salter derav, fremgangsmaate for fremstilling derav og antimikrobielt middel inneholdende slike.
DK0916651T3 (da) Phenylalkylcarboxylsyrederivater
ATE149491T1 (de) Aminopyridinderivate, verfahren zu ihrer herstellung und ihrer verwendung
DE3578178D1 (de) Beta-carbolin-3-carbonsaeurederivate, verfahren zu ihrer herstellung und ihre verwendung.
ATE100097T1 (de) Benzoxepin-derivate.
DE69425266D1 (de) Optisch aktive imidazolidinon-derivate und verfahren zu deren herstellung
ES2111086T3 (es) Compuestos triciclicos anfoteros como agentes antihistaminicos y antialergicos.
ATE189887T1 (de) Vitamin-d-derivat und verfahren zu seiner herstellung
EP0657443A4 (de) Optisch aktive carboxamidderivate.
DK0654473T3 (da) Cyclopropanderivater og antivirale midler med indhold deraf
DE69500198D1 (de) Zns mittel, verfahren zu seiner herstellung und dieses enthaltende pharmazeutische zubereitungen
DE69300318D1 (de) Flavonderivate.
ATE143957T1 (de) Aminoalkylchomone, verfahren für ihre herstellung und die enthaltende pharmazeutische zusammensetzungen
DE3884518D1 (de) Naphthothiazepin-derivate und verfahren zu ihrer herstellung.
DE69837628D1 (de) Aminderivate, verfahren zu ihrer herstellung und ihre verwendung als antimykotische mittel
NO175255C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive alkylestere av 2-(4-(2-piperidino-etoksy)-benzoyl)-benzosyre med forgrenet kjede
HU9301288D0 (en) Method for producing new enantiomers derived from (s)-2-amino-(3,4-dichlorine-benzyl)-1-propanole
CA2122705A1 (en) Optically Active 1-Phenylpyrrolidone Derivative, Intermediate for Producing the Same, and Process for Producing Both

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0656360

Country of ref document: EP

REN Ceased due to non-payment of the annual fee